Skip to content
  • About RCMI
    • RCMI Overview
    • RCMI CC Senior Management
    • RCMI Steering Committee
    • RCMI External Advisory Committee
  • RCMI Events
  • RCMI News
  • NIMHD News
  • Contact

Research Centers in Minority Institutions – Coordinating Center (RCMI-CC)

  • Research
    Database
  • Tools &
    Resources
  • Institution
    Directory
  • Funding
    Opportunities
Toggle Navigation

News from the Network

May 11, 2023 / Clark Atlanta University

Dr. Xin Li received a $50,000 Seed Award from Prostate Cancer Research, Inc.

Dr. Xin Li at Clark Atlanta University has been granted a $50,000 highly competitive Disparities Seed Award from Prostate Cancer Research (PCR), Inc. PCR is… Continue Reading

April 21, 2022 / Clark Atlanta University

Purification and Identification of Natural Inhibitors of Protein Arginine Methyltransferases from Plants

Protein arginine methyltransferase (PRMT) enzymes catalyze posttranslational modifications of target proteins and are often upregulated in human cancers. In this study, we purified two chemical…

November 12, 2021 / Clark Atlanta University

Overcoming prostate cancer drug resistance with a novel organosilicon small molecule. Neoplasia, 23:1261-1274, 2021.

A major challenge to the treatment of advanced prostate cancer (PCa) is the development of resistance to androgen-deprivation therapy (ADT) and chemotherapy…

August 25, 2021 / Clark Atlanta University

Epithelial protein lost in neoplasm (EPLIN) and prostate cancer: lessons learned from the ARCaP model. American Journal of Clinical and Experimental Urology, 9:264-276, 2021.

Confucius said, “Good tools are prerequisite to the successful execution of a job”. Among his many groundbreaking achievements, Dr. Leland W. K. Chung established several… Continue Reading

May 8, 2021 / Clark Atlanta University

Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer Theranostics, 11:6873-6890, 2021

Prostate cancer (PCa) is the most commonly diagnosed cancer and the second leading cause of cancer death among American men 1. As the first-line chemotherapy for… Continue Reading

© 2023 Research Centers in Minority Institutions Coordinating Center (RCMI CC)

Research Centers in Minority Institutions (RCMI) Coordinating Center is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.

  • Legal / Privacy
  • Site Map
  • Research
    Database
  • Tools &
    Resources
  • Institution
    Directory
  • Funding
    Opportunities
  • RCMI News
  • NIMHD News
  • About RCMI
  • Contact
  • RCMI Login
  • Research
    Database
  • Tools &
    Resources
  • Institution
    Directory
  • Funding
    Opportunities
  • About RCMI
    • RCMI Overview
    • RCMI CC Senior Management
    • RCMI Steering Committee
    • RCMI External Advisory Committee
  • RCMI Events
  • RCMI News
  • NIMHD News
  • Contact
Toggle Navigation